Blue Light Imaging and Linked Color Imaging for the Characterization of Mucosal Changes in Chronic Gastritis: A Clinicians View and Brief Technical Report.
Weigt J. et al, (2020), Digestive diseases (Basel, Switzerland), 38, 9 - 14
Development and validation of a risk prediction model to diagnose Barrett's oesophagus (MARK-BE): a case-control machine learning approach
Rosenfeld A. et al, (2020), The Lancet Digital Health, 2, e37 - e48
The Rationale and Efficacy of Primary and Secondary Prevention in Adenocarcinomas of the Upper Gastrointestinal Tract.
Bornschein J. et al, (2019), Digestive diseases (Basel, Switzerland), 37, 381 - 393
Diminutive polyps and future colorectal cancer risk perception: how low do we need to go?
Bird-Lieberman E. and East J., (2018), Endoscopy, 50, 197 - 199
MMP2 and MMP7 at the invasive front of gastric cancer are not associated with mTOR expression
Bornschein J. et al, (2015), Diagnostic Pathology, 10
Autofluorescence-Directed Confocal Endomicroscopy in Combination With a Three-Biomarker Panel Can Inform Management Decisions in Barrett’s Esophagus
di Pietro M. et al, (2015), American Journal of Gastroenterology, 110, 1549 - 1558
Autofluorescence-directed confocal endomicroscopy in combination with a three-biomarker panel can inform management decisions in barrett's esophagus
Di Pietro M. et al, (2015), American Journal of Gastroenterology, 110, 1549 - 1558
FIRST IN-VIVO STUDY ON THE USE OF LECTIN-BASED MOLECULAR IMAGING IN BARRETT'S OESOPHAGUS
Di Pietro M. et al, (2015), GUT, 64, A21 - A21
Electronic imaging to enhance lesion detection at colonoscopy
Ket SN. et al, (2015), Gastrointestinal Endoscopy Clinics of North America, 25, 227 - 242
Electronic Imaging to Enhance Lesion Detection at Colonoscopy
Ket SN. et al, (2015), Gastrointestinal Endoscopy Clinics of North America, 25, 227 - 242
OC-017 Autofluorescence-targeted Optical Biopsy Accurately Diagnoses Dysplasia In Barrett’s Oesophagus And Can Detect The Field Of Molecular Change
Di Pietro M. et al, (2014), Gut, 63, A8.2 - A9
Autofluorescence-Targeted Optical Biopsy Accurately Diagnoses Dysplasia in Barrett's Esophagus and Can Detect the Field of Molecular Change
di Pietro M. et al, (2014), GASTROENTEROLOGY, 146, S312 - S312
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus
Fitzgerald RC. et al, (2014), Gut, 63, 7 - 42
PTU-156 The Combination of Autofluorescence Imaging and Probe-Based Confocal Laser Endomicroscopy has an Excellent Diagnostic Accuracy for Dysplasia in Barrett’S Esophagus
Pietro MD. et al, (2013), Gut, 62, A111.3 - A112
In Vitro Toxicity Studies of Novel Lectin Probes Which Have Potential to Allow Endoscopic Detection of Dysplasia in Barrett's Esophagus During Surveillance
Bird-Lieberman EL. et al, (2013), GASTROENTEROLOGY, 144, S688 - S688
Lewis Biomarkers for Detection of Dysplasia in Barrett's Esophagus
Bird-Lieberman EL. et al, (2013), GASTROENTEROLOGY, 144, S352 - S352
Population-Based Study Reveals New Risk-Stratification Biomarker Panel for Barrett's Esophagus
Bird–Lieberman EL. et al, (2012), Gastroenterology, 143, 927 - 935.e3
Randomized crossover study comparing efficacy of transnasal endoscopy with that of standard endoscopy to detect Barrett's esophagus
Shariff MK. et al, (2012), Gastrointestinal Endoscopy, 75, 954 - 961
Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus
Bird-Lieberman EL. et al, (2012), Nature Medicine, 18, 315 - 321
Phase 3 Population-Based Study Reveals New Risk-Stratification Biomarker Panel for Barrett's Esophagus
Dunn JM. et al, (2011), GASTROENTEROLOGY, 140, S136 - S136